Europe — EMA
Paliperidon Genericon (Paliperidone Palmitate)
Paliperidone Palmitate, the active ingredient in Paliperidon Genericon, is an antipsychotic presented as a long‑acting injectable suspension for intramuscular use.
Request sourcing
What is Paliperidone Palmitate?
Paliperidone Palmitate, the active ingredient in Paliperidon Genericon, is an antipsychotic presented as a long‑acting injectable suspension for intramuscular use. It is indicated for the maintenance treatment of schizophrenia in adult patients. GNH USA supplies Paliperidon Genericon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
GNH USA supplies Paliperidon Genericon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Paliperidone Palmitate used for?
Paliperidon Genericon is an antipsychotic medication used in the management of schizophrenia, acting on dopaminergic pathways to control psychotic symptoms.
- Schizophrenia: helps maintain symptom control and reduces risk of relapse. - Schizoaffective disorder: contributes to stabilization of mood and psychotic features. - Bipolar I disorder (maintenance): assists in preventing manic or depressive episodes when used as part of a broader treatment plan.
What are the side effects of Paliperidone Palmitate?
Paliperidon Genericon may cause a range of adverse reactions, most of which are dose‑dependent and reversible.
Common Side Effects: - Injection site pain - Weight gain - Akathisia (inner‑restlessness - Drowsiness - Constipation - Dry mouth
Serious or Rare Side Effects: - Neuroleptic malignant syndrome - Tardive dyskinesia - Seizures - Orthostatic hypotension - Hyperglycaemia - Elevated C‑ C g g t d ight ight ight ight ight
